Literature DB >> 24556217

Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis.

Bumsup Kwon1, Pravir Kumar2, Han-Kyu Lee1, Ling Zeng3, Kenneth Walsh3, Qinghao Fu4, Amey Barakat4, Henry W Querfurth5.   

Abstract

Inclusion body myositis (IBM), a degenerative and inflammatory disorder of skeletal muscle, and Alzheimer's disease share protein derangements and attrition of postmitotic cells. Overexpression of cyclins and proliferating cell nuclear antigen (PCNA) and evidence for DNA replication is reported in Alzheimer's disease brain, possibly contributing to neuronal death. It is unknown whether aberrant cell cycle reentry also occurs in IBM. We examined cell cycle markers in IBM compared with normal control, polymyositis (PM) and non-inflammatory dystrophy sample sets. Next, we tested for evidence of reentry and DNA synthesis in C2C12 myotubes induced to express β-amyloid (Aβ42). We observed increased levels of Ki-67, PCNA and cyclins E/D1 in IBM compared with normals and non-inflammatory conditions. Interestingly, PM samples displayed similar increases. Satellite cell markers did not correlate with Ki-67-affected myofiber nuclei. DNA synthesis and cell cycle markers were induced in Aβ-bearing myotubes. Cell cycle marker and cyclin protein expressions were also induced in an experimental allergic myositis-like model of PM in mice. Levels of p21 (Cip1/WAF1), a cyclin-dependent kinase inhibitor, were decreased in affected myotubes. However, overexpression of p21 did not rescue cells from Aβ-induced toxicity. This is the first report of cell cycle reentry in human myositis. The absence of rescue and evidence for reentry in separate models of myodegeneration and inflammation suggest that new DNA synthesis may be a reactive response to either or both stressors.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24556217      PMCID: PMC4065145          DOI: 10.1093/hmg/ddu077

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  99 in total

Review 1.  Cyclins: roles in mitogenic signaling and oncogenic transformation.

Authors:  Elizabeth A Musgrove
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

Review 2.  Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.

Authors:  Valerie Askanas; W King Engel
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

3.  Bim is elevated in Alzheimer's disease neurons and is required for beta-amyloid-induced neuronal apoptosis.

Authors:  Subhas C Biswas; Yijie Shi; Jean-Paul G Vonsattel; Conrad L Leung; Carol M Troy; Lloyd A Greene
Journal:  J Neurosci       Date:  2007-01-24       Impact factor: 6.167

4.  Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models.

Authors:  Yan Yang; Nicholas H Varvel; Bruce T Lamb; Karl Herrup
Journal:  J Neurosci       Date:  2006-01-18       Impact factor: 6.167

Review 5.  Cell division in the CNS: protective response or lethal event in post-mitotic neurons?

Authors:  Yan Yang; Karl Herrup
Journal:  Biochim Biophys Acta       Date:  2006-10-07

6.  Neuronal cell cycle re-entry mediates Alzheimer disease-type changes.

Authors:  Andrew McShea; Hyoung-gon Lee; Robert B Petersen; Gemma Casadesus; Inez Vincent; Nancy J Linford; Jens-Oliver Funk; Robert A Shapiro; Mark A Smith
Journal:  Biochim Biophys Acta       Date:  2006-10-03

7.  A new murine model to define the critical pathologic and therapeutic mediators of polymyositis.

Authors:  Takahiko Sugihara; Chiyoko Sekine; Takashi Nakae; Kuniko Kohyama; Masayoshi Harigai; Yoichiro Iwakura; Yoh Matsumoto; Nobuyuki Miyasaka; Hitoshi Kohsaka
Journal:  Arthritis Rheum       Date:  2007-04

8.  Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice.

Authors:  Kevin H J Park; Janice L Hallows; Paramita Chakrabarty; Peter Davies; Inez Vincent
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

9.  The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease.

Authors:  Günter U Höglinger; Joshua J Breunig; Candan Depboylu; Caroline Rouaux; Patrick P Michel; Daniel Alvarez-Fischer; Anne-Laurence Boutillier; James Degregori; Wolfgang H Oertel; Pasko Rakic; Etienne C Hirsch; Stéphane Hunot
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

10.  Critical requirement for cell cycle inhibitors in sustaining nonproliferative states.

Authors:  Deborah Pajalunga; Alessia Mazzola; Anna Maria Salzano; Maria Grazia Biferi; Gabriele De Luca; Marco Crescenzi
Journal:  J Cell Biol       Date:  2007-03-12       Impact factor: 10.539

View more
  7 in total

1.  Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus.

Authors:  Nagendran Tharmalingam; Elamparithi Jayamani; Rajmohan Rajamuthiah; Dawilmer Castillo; Beth Burgwyn Fuchs; Michael J Kelso; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2017-08-03       Impact factor: 3.808

2.  Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds.

Authors:  Elamparithi Jayamani; Nagendran Tharmalingam; Rajmohan Rajamuthiah; Jeffrey J Coleman; Wooseong Kim; Ikechukwu Okoli; Ana M Hernandez; Kiho Lee; Gerard J Nau; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.

Authors:  Rajmohan Rajamuthiah; Beth Burgwyn Fuchs; Annie L Conery; Wooseong Kim; Elamparithi Jayamani; Bumsup Kwon; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

4.  Skeletal muscle microRNA and messenger RNA profiling in cofilin-2 deficient mice reveals cell cycle dysregulation hindering muscle regeneration.

Authors:  Sarah U Morton; Mugdha Joshi; Talia Savic; Alan H Beggs; Pankaj B Agrawal
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 5.  Inclusion Body Myositis and Neoplasia: A Narrative Review.

Authors:  Laura Damian; Cristian Cezar Login; Carolina Solomon; Cristina Belizna; Svetlana Encica; Laura Urian; Ciprian Jurcut; Bogdan Stancu; Romana Vulturar
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

6.  Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.

Authors:  Nagendran Tharmalingam; Jenna Port; Dawilmer Castillo; Eleftherios Mylonakis
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

7.  Butenafine and analogues: An expeditious synthesis and cytotoxicity and antifungal activities.

Authors:  Ana María Garzón Porras; Bruna Silva Terra; Taniris Cafiero Braga; Thais Furtado Ferreira Magalhães; Cleide Viviane Buzanello Martins; Danielle Letícia da Silva; Ludmila Matos Baltazar; Ludmila Ferreira Gouveia; Gustavo José Cota de Freitas; Daniel Assis Santos; Maria Aparecida Resende-Stoianoff; Beth Burgwyn Fuchs; Eleftherios Mylonakis; Rossimiriam Pereira de Freitas; Ângelo de Fátima
Journal:  J Adv Res       Date:  2018-06-21       Impact factor: 10.479

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.